These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 752007

  • 1. Persistent hypocomplementemia in membrano-proliferative glomerulonephritis.
    J Assoc Physicians India; 1978 Dec; 26(12):1167-70. PubMed ID: 752007
    [No Abstract] [Full Text] [Related]

  • 2. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R, Lévy M, Gubler MC, Broyer M, Habib M.
    Arch Fr Pediatr; 1977 Dec; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [Abstract] [Full Text] [Related]

  • 3. The natural history of membranoproliferative glomerulonephritis: its relation to the hypocomplementemia.
    West CD, Ruley EJ, Spitzer RE, Davis NC.
    Perspect Nephrol Hypertens; 1973 Dec; 1 Pt 1():531-40. PubMed ID: 4620926
    [No Abstract] [Full Text] [Related]

  • 4. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP, Kourilsky O, Morel-Maroger L, Adam C.
    N Engl J Med; 1978 May 04; 298(18):1034. PubMed ID: 643001
    [No Abstract] [Full Text] [Related]

  • 5. The complement abnormalities of lipodystrophy.
    Sissons JG, West RJ, Fallows J, Williams DG, Boucher BJ, Amos N, Peters DK.
    N Engl J Med; 1976 Feb 26; 294(9):461-5. PubMed ID: 1246331
    [Abstract] [Full Text] [Related]

  • 6. The role of complement in glomerulonephritis.
    Simpson IJ.
    Aust N Z J Med; 1981 Feb 26; 11(Suppl 1):101-3. PubMed ID: 6942797
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M.
    Clin Exp Immunol; 1986 Jul 26; 65(1):73-9. PubMed ID: 3641694
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E, Yagüe J, Vives J, Revert L.
    Med Clin (Barc); 1981 Jun 10; 77(1):21-6. PubMed ID: 7253758
    [Abstract] [Full Text] [Related]

  • 13. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A, Montagnino G, Scalia P, Tarantino A.
    Ric Clin Lab; 1980 Jun 10; 10(1):93-7. PubMed ID: 6781054
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
    Peters DK, Williams DG.
    Adv Nephrol Necker Hosp; 1974 Jun 10; 4():67-78. PubMed ID: 4220000
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Complement].
    Kourilsky O.
    Ric Clin Lab; 1977 Jun 10; 7 Suppl 2():31-55. PubMed ID: 594564
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term observation of persistent hypocomplementaemia in three patients with membranoproliferative glomerulonephritis].
    Watanabe S, Ohi H, Seki M, Fujita T, Hatano M, Nawa N.
    Nihon Naika Gakkai Zasshi; 1987 Jan 10; 76(1):106-11. PubMed ID: 3572149
    [No Abstract] [Full Text] [Related]

  • 19. [Chronic urticaria and acquired complement deficiency due to a nephritic factor (C3NeF)].
    Borradori L, Rybojad M, Weiss L, Späth P, Puissant A, Morel P.
    Schweiz Med Wochenschr; 1990 Aug 25; 120(34):1236-41. PubMed ID: 2218445
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.